We are live on ! Find out more
UTHR icon

United Therapeutics
UTHR

411 hedge funds and large institutions have $6.46B invested in United Therapeutics in 2017 Q1 according to their latest regulatory filings, with 52 funds opening new positions, 153 increasing their positions, 143 reducing their positions, and 40 closing their positions.

New
Increased
Maintained
Reduced
Closed

30% more first-time investments, than exits

New positions opened: 52 | Existing positions closed: 40

1% more funds holding

Funds holding: 406 → 411 (+5)

7% more repeat investments, than reductions

Existing positions increased: 153 | Existing positions reduced: 143

4% less call options, than puts

Call options by funds: $82.5M | Put options by funds: $85.8M

5% less capital invested

Capital invested by funds: $6.81B → $6.46B (-$347M)

5.74% less ownership

Funds ownership: 112% → 106.25% (-5.7%)

14% less funds holding in top 10

Funds holding in top 10: 7 → 6 (-1)

Holders
411
Holders Change
+5
Holders Change %
+1.23%
% of All Funds
10.23%
Holding in Top 10
6
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-14.29%
% of All Funds
0.15%
New
52
Increased
153
Reduced
143
Closed
40
Calls
$82.5M
Puts
$85.8M
Net Calls
-$3.27M
Net Calls Change
+$3.65M

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$702M
2
AQR Capital Management
AQR Capital Management
Connecticut
+$57.2M
3
Goldman Sachs
Goldman Sachs
New York
+$42.9M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$38.9M
5
BNP Paribas Financial Markets
BNP Paribas Financial Markets
France
+$32.6M

Top Sellers

Rank Fund Capital Flow
1
SCM
Scopia Capital Management
New York
-$133M
2
AL
AJO LP
Pennsylvania
-$46.5M
3
NI
Numeric Investors
Massachusetts
-$38.9M
4
Deutsche Bank
Deutsche Bank
Germany
-$38.2M
5
STMM
South Texas Money Management
Texas
-$26.8M
Name Holding Trade Value Shares
Change 		Change in
Stake
NYLT
401
New York Life Trust
New York
$3K +$3.79K +25 New
MCM
402
MV Capital Management
Maryland
$2K – – –
WAM
403
Wealthspire Advisors (Maryland)
Maryland
$2K +$1.67K +11 +275%
ATC
404
Adirondack Trust Company
New York
$2K +$2.12K +14 New
ZB
405
Zions Bancorporation
Utah
$1K -$1.36K -9 -60%
ACS
406
Archford Capital Strategies
Illinois
$1K – – –
OFW
407
Omnia Family Wealth
Florida
$1K – – –
VCM
408
Versant Capital Management
Arizona
$1K – – –
WA
409
Winfield Associates
Ohio
$1K – – –
KKAMG
410
Kernodle & Katon Asset Management Group
Arkansas
$1K +$1.51K +10 New
Walleye Trading
411
Walleye Trading
New York
$19 -$900K -5,940 -98%
STMM
412
South Texas Money Management
Texas
– -$26.8M -186,519 Closed
FCM
413
Frontier Capital Management
Massachusetts
– -$20M -139,264 Closed
AIG
414
American International Group
New York
– -$12M -83,995 Closed
AC
415
Amici Capital
New York
– -$11.6M -81,032 Closed
AIMCA
416
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
– -$4.68M -32,600 Closed
ARTA
417
A.R.T. Advisors
New York
– -$4.62M -32,200 Closed
Teacher Retirement System of Texas
418
Teacher Retirement System of Texas
Texas
– -$4.54M -31,632 Closed
LMIM
419
Lockheed Martin Investment Management
Maryland
– -$2.84M -19,780 Closed
Fiera Capital (Canada)
420
Fiera Capital (Canada)
Quebec, Canada
– -$2.57M -17,886 Closed
OA
421
Oxbow Advisors
Texas
– -$2.43M -16,930 Closed
Capital Fund Management (CFM)
422
Capital Fund Management (CFM)
France
– -$1.76M -12,243 Closed
Jane Street
423
Jane Street
New York
– -$1.27M -8,886 Closed
Simplex Trading
424
Simplex Trading
Illinois
– -$1.26M -8,307 Closed
PL
425
Polianta Ltd
Jersey
– -$1.16M -8,100 Closed
15 16
17
18 19

UTHR Hedge Fund Activity: Q1 2017 in Review

411 of the 4,018 institutional investors tracked by Wall St. Rank reported a position in United Therapeutics (UTHR) for Q1 2017, worth a combined $6.46B — down 5.1% from $6.81B a quarter earlier.

Buyers outnumbered sellers: 52 funds opened new UTHR positions and 40 closed out — a net gain of 12 holders — while 153 added to existing stakes and 143 trimmed.

The largest buyer was BlackRock, adding an estimated $702M. The largest seller was Scopia Capital Management, cutting an estimated $133M.

  • 411 institutional investors held United Therapeutics (UTHR) as of Q1 2017, up from 406 in Q4 2016.
  • Funds reported $6.46B of United Therapeutics stock for Q1 2017, down 5.1% quarter-over-quarter.
  • 52 funds opened new United Therapeutics positions in Q1 2017 and 40 closed out, a net change of +12 holders.
  • The largest United Therapeutics buyer in Q1 2017 was BlackRock, an estimated $702M added.
  • The largest United Therapeutics seller in Q1 2017 was Scopia Capital Management, an estimated $133M sold.

Based on aggregated 13F filings for Q1 2017.